Induction Healthcare Group PLC (INHC:LSE) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Induction Healthcare Group PLC stock forecast from 0 analysts, the average analyst target price for Induction Healthcare Group PLC is not available over the next 12 months. Induction Healthcare Group PLC’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Induction Healthcare Group PLC is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Induction Healthcare Group PLC’s stock price was GBX 12.50. Induction Healthcare Group PLC’s stock price has changed by -10.71% over the past week, -7.41% over the past month and -44.44% over the last year.
No recent analyst target price found for Induction Healthcare Group PLC
No recent average analyst rating found for Induction Healthcare Group PLC
Company Overview Induction Healthcare Group PLC
Induction Healthcare Group PLC provides software to healthcare professionals in the United Kingdom, Europe, the United States, and internationally. It offers Induction Switch, hospital staff directory app that enables users to source, communicate, and share information with other healthcare professionals, as well as allows them to bypass legacy hospital switchboards; Induction Zesty, a digital patient engagement platform that ensures automated process for patients to manage their hospital appointments, view their letters and clinical records, as well as provides data remotely via digital questionnaires; Induction Guidance, a platform to create, edit, and publish their own local medical guidance and policies; and Induction Attend Anywhere, which offers video consultations to patients and service users to help hospitals, health systems, and other customers. Induction Healthcare Group PLC was incorporated in 2019 and is based in London, the United Kingdom. Read Less
Induction Healthcare Group PLC provides software to healthcare professionals in the United Kingdom, Europe, the United States, and internationally. It offers Induction Switch, hospital staff directory app that enables users to source, communicate, and share information with other...Read More
Frequently Asked Questions About Induction Healthcare Group PLC (INHC:LSE) Stock
Stock Target Advisor's fundamental analysis for Induction Healthcare Group PLC's stock is Bearish.
Unfortunately we do not have enough data on INHC:LSE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on INHC:LSE's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on INHC:LSE's stock to indicate if its overvalued.
The last closing price of INHC:LSE's stock was GBX 12.50.
The most recent market capitalization for INHC:LSE is GBX 0.01B.
Unfortunately we do not have enough analyst data on INHC:LSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Induction Healthcare Group PLC's stock.
As per our most recent records Induction Healthcare Group PLC has 83 Employees.
Induction Healthcare Group PLC's registered address is Pinsent Masons, London, United Kingdom, EC2A 4ES.
You can get more information about it from Induction Healthcare Group PLC's website at https://inductionhealthcare.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for INHC:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
